Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Dipeptidyl peptidase 9 | ||
Ligand | BDBM50221976 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_449745 (CHEMBL898848) | ||
IC50 | 50000±n/a nM | ||
Citation | Kaelin, DE; Smenton, AL; Eiermann, GJ; He, H; Leiting, B; Lyons, KA; Patel, RA; Patel, SB; Petrov, A; Scapin, G; Wu, JK; Thornberry, NA; Weber, AE; Duffy, JL 4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV. Bioorg Med Chem Lett17:5806-11 (2007) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Dipeptidyl peptidase 9 | |||
Name: | Dipeptidyl peptidase 9 | ||
Synonyms: | DPP9 | DPP9_HUMAN | DPRP-2 | DPRP2 | Dipeptidyl peptidase 9 (DDP9) | Dipeptidyl peptidase 9 (DPP-9) | Dipeptidyl peptidase 9 (DPP9) | Dipeptidyl peptidase IV-related protein 2 | Dipeptidyl peptidase IX | Dipeptidyl peptidase IX (DDP-IX) | Dipeptidyl peptidase-like protein 9 | ||
Type: | Enzyme | ||
Mol. Mass.: | 98260.70 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q86TI2 | ||
Residue: | 863 | ||
Sequence: |
| ||
BDBM50221976 | |||
n/a | |||
Name | BDBM50221976 | ||
Synonyms: | (2S,3S)-3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-((1s,4R)-4-(5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-yl)cyclohexyl)butanamide | CHEMBL235198 | ||
Type | Small organic molecule | ||
Emp. Form. | C22H34F2N6O2 | ||
Mol. Mass. | 452.5412 | ||
SMILES | CN(C)C(=O)[C@H]([C@H](N)C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](CC1)C1CCc2ncnn2C1 |w:23.34,wU:6.6,17.23,20.24,wD:5.4,(1.03,-21.75,;1.04,-23.29,;-.29,-24.06,;2.38,-24.05,;3.71,-23.28,;2.38,-25.59,;3.72,-26.36,;3.72,-27.9,;5.05,-25.58,;5.04,-24.04,;6.39,-26.35,;7.8,-25.71,;8.83,-26.85,;8.06,-28.19,;7.65,-29.67,;9.59,-28.42,;6.56,-27.88,;1.05,-26.37,;1.06,-27.92,;-.28,-28.69,;-1.61,-27.92,;-1.61,-26.37,;-.28,-25.6,;-2.95,-28.69,;-2.94,-30.22,;-4.27,-30.99,;-5.61,-30.22,;-7.08,-30.7,;-8,-29.46,;-7.09,-28.2,;-5.62,-28.68,;-4.28,-27.91,)| | ||
Structure |